Significantly reduced conflict between adolescents with ADHD and family members

Mean Percent Change From Baseline in Child Conflict Index as Rated by Parents (n=174)¹

Adapted from Wilens et al, 2006.

*A multisite, double-blind study in 177 adolescents with ADHD, aged 13 to 18 years. Patients received CONCERTA® 18-72 mg or placebo.

CONCERTA® significantly reduced conflict between adolescents with ADHD and family members as rated by parents, such as1-2

  • Improved compliance with parent requests
  • Less complaining/whining
  • Fewer bad moods

References: 1. Wilens TE, McBurnett K, Bukstein O, et al. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2006;160:82-90. 2. Data on file (CON007), McNeil Pediatrics.